Fiduciary Trust Co Sells 121 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Fiduciary Trust Co reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,915 shares of the financial services provider’s stock after selling 121 shares during the quarter. Fiduciary Trust Co’s holdings in iShares Biotechnology ETF were worth $1,007,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter worth $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter valued at about $30,000. Bbjs Financial Advisors LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at about $31,000. Ashton Thomas Securities LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth about $36,000. Finally, Voisard Asset Management Group Inc. bought a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $59,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $141.55 on Friday. iShares Biotechnology ETF has a twelve month low of $119.95 and a twelve month high of $150.57. The firm has a 50 day moving average of $142.84 and a 200 day moving average of $141.96.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.